Notice: Our website will be down for maintenance from June 13 - June 14.

Novo Nordisk Receives FDA Approval for Hemophilia A Treatment

The following is an excerpt from a press release. Read the press release in its entirety here. Denmark-based Novo Nordisk received approval from the U.S. Food and Drug Administration for a new treatment for hemophilia A. However, the newly approved medication will not be available in the United States until 2020.Novo Nordisk said the FDA […]

en_USEnglish